Published in J Neuropathol Exp Neurol on January 01, 2015
Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains. Alzheimers Res Ther (2015) 0.89
Microglia in action: how aging and injury can change the brain's guardians. Front Cell Neurosci (2015) 0.85
Cellular and Molecular Mechanisms Underpinning Macrophage Activation during Remyelination. Front Cell Dev Biol (2016) 0.84
Myeloid cells - targets of medication in multiple sclerosis. Nat Rev Neurol (2016) 0.83
Myelin damage and repair in pathologic CNS: challenges and prospects. Front Mol Neurosci (2015) 0.83
Microglia-Neuron Communication in Epilepsy. Glia (2016) 0.78
Parallel Aspects of the Microenvironment in Cancer and Autoimmune Disease. Mediators Inflamm (2016) 0.78
Role of Microglia in Neurological Disorders and Their Potentials as a Therapeutic Target. Mol Neurobiol (2016) 0.77
Advanced MRI and staging of multiple sclerosis lesions. Nat Rev Neurol (2016) 0.77
Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions. J Clin Invest (2016) 0.77
Translational utility of experimental autoimmune encephalomyelitis: recent developments. J Inflamm Res (2015) 0.76
Pioglitazone regulates myelin phagocytosis and multiple sclerosis monocytes. Ann Clin Transl Neurol (2015) 0.76
Multiple Sclerosis and Obesity: Possible Roles of Adipokines. Mediators Inflamm (2016) 0.76
Expression of IL-1β in rhesus EAE and MS lesions is mainly induced in the CNS itself. J Neuroinflammation (2016) 0.76
Inflammation after Ischemic Stroke: The Role of Leukocytes and Glial Cells. Exp Neurobiol (2016) 0.76
Neuroadhesive L1 coating attenuates acute microglial attachment to neural electrodes as revealed by live two-photon microscopy. Biomaterials (2016) 0.76
Complement C3 on microglial clusters in multiple sclerosis occur in chronic but not acute disease: Implication for disease pathogenesis. Glia (2016) 0.75
Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging. Acta Neuropathol (2016) 0.75
Ageing and recurrent episodes of neuroinflammation promote progressive experimental autoimmune encephalomyelitis in Biozzi ABH mice. Immunology (2016) 0.75
Demyelination patterns in a mathematical model of multiple sclerosis. J Math Biol (2016) 0.75
Multiple Sclerosis: Immunopathology and Treatment Update. Brain Sci (2017) 0.75
Inflammation in neurodegenerative diseases. Immunology (2010) 3.22
Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis. Nat Biotechnol (2003) 2.80
The macrophage scavenger receptor CD163. Immunobiology (2005) 2.44
Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann Neurol (2008) 2.29
A randomised cross-over trial investigating the ease of use and preference of two dry powder inhalers in patients with asthma or chronic obstructive pulmonary disease. Expert Opin Drug Deliv (2013) 2.13
The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria. Blood (2008) 1.96
Receptor conversion in distant breast cancer metastases. Breast Cancer Res (2010) 1.85
The pathology of multiple sclerosis is location-dependent: no significant complement activation is detected in purely cortical lesions. J Neuropathol Exp Neurol (2005) 1.76
Macrophages and neurodegeneration. Brain Res Brain Res Rev (2005) 1.64
Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J (2007) 1.63
Critical appraisal of animal models of multiple sclerosis. Mult Scler (2011) 1.61
Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status. J Neuroinflammation (2013) 1.59
Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice. J Clin Invest (2003) 1.59
Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. Arch Neurol (2003) 1.55
Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs. J Immunol (2002) 1.54
Identification of a microglia phenotype supportive of remyelination. Glia (2011) 1.51
Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Brain (2005) 1.51
Extensive hippocampal demyelination in multiple sclerosis. J Neuropathol Exp Neurol (2007) 1.40
Interferon-beta directly influences monocyte infiltration into the central nervous system. J Neuroimmunol (2002) 1.35
Diapedesis of monocytes is associated with MMP-mediated occludin disappearance in brain endothelial cells. FASEB J (2006) 1.34
Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration? Mitochondrion (2010) 1.34
Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis. J Exp Med (2004) 1.34
Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Arch Neurol (2007) 1.32
Lipoic acid affects cellular migration into the central nervous system and stabilizes blood-brain barrier integrity. J Immunol (2006) 1.30
Inflammation in neurodegenerative diseases--an update. Immunology (2014) 1.30
CD163-positive perivascular macrophages in the human CNS express molecules for antigen recognition and presentation. Glia (2005) 1.30
Enhanced number and activity of mitochondria in multiple sclerosis lesions. J Pathol (2009) 1.29
Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis. Arch Neurol (2009) 1.26
Signal-regulatory protein alpha-CD47 interactions are required for the transmigration of monocytes across cerebral endothelium. J Immunol (2002) 1.26
The rat macrophage scavenger receptor CD163: expression, regulation and role in inflammatory mediator production. Immunobiology (2006) 1.25
The blood-brain barrier in cortical multiple sclerosis lesions. J Neuropathol Exp Neurol (2007) 1.20
In vitro and in vivo models of multiple sclerosis. CNS Neurol Disord Drug Targets (2012) 1.20
Tissue distribution and induction of human multidrug resistant protein 3. Lab Invest (2002) 1.19
Prognostic value of estrogen receptor α and progesterone receptor conversion in distant breast cancer metastases. Cancer (2012) 1.18
Expression and cellular distribution of multidrug resistance-related proteins in the hippocampus of patients with mesial temporal lobe epilepsy. Epilepsia (2004) 1.17
Preactive lesions in multiple sclerosis. Curr Opin Neurol (2009) 1.16
RhoA activation promotes transendothelial migration of monocytes via ROCK. J Leukoc Biol (2003) 1.16
Sphingosine 1-phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions. Glia (2010) 1.15
Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis. Neurobiol Dis (2005) 1.14
Matrix metalloproteinase-12 is expressed in phagocytotic macrophages in active multiple sclerosis lesions. J Neuroimmunol (2003) 1.14
Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE. J Mol Med (Berl) (2008) 1.14
A qualitative evaluation of a comprehensive self-management programme for COPD patients: effectiveness from the patients' perspective. Patient Educ Couns (2004) 1.13
Community based physiotherapeutic exercise in COPD self-management: a randomised controlled trial. Respir Med (2010) 1.13
Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain. Epilepsia (2005) 1.12
Post-traumatic cutaneous meningioma. J Laryngol Otol (2004) 1.11
Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation. J Neuroinflammation (2012) 1.09
Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis. Brain (2009) 1.09
Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons. Acta Neuropathol (2013) 1.08
Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis. Mult Scler (2011) 1.08
Alphab-crystallin is a target for adaptive immune responses and a trigger of innate responses in preactive multiple sclerosis lesions. J Neuropathol Exp Neurol (2010) 1.07
Prognostic factors in adult soft tissue sarcomas of the head and neck: a single-centre experience. Oral Oncol (2006) 1.06
Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions. Glia (2012) 1.05
Expression and localization of inhibitor of apoptosis proteins in normal human tissues. Hum Pathol (2005) 1.05
Differential effects of combined Ad5- delta 24RGD and radiation therapy in in vitro versus in vivo models of malignant glioma. Clin Cancer Res (2007) 1.04
High incidence of spontaneous disease in an HLA-DR15 and TCR transgenic multiple sclerosis model. J Immunol (2005) 1.04
Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology. Brain Res Rev (2007) 1.04
Human endogenous retrovirus type W envelope protein inhibits oligodendroglial precursor cell differentiation. Ann Neurol (2013) 1.04
Axonal loss and gray matter pathology as a direct result of autoimmunity to neurofilaments. Neurobiol Dis (2008) 1.02
Signal regulatory protein alpha ligation induces macrophage nitric oxide production through JAK/STAT- and phosphatidylinositol 3-kinase/Rac1/NAPDH oxidase/H2O2-dependent pathways. Mol Cell Biol (2005) 1.02
In vivo detection of myelin proteins in cervical lymph nodes of MS patients using ultrasound-guided fine-needle aspiration cytology. J Neuroimmunol (2005) 1.02
Publication guidelines for refereeing and reporting on animal use in experimental autoimmune encephalomyelitis. J Neuroimmunol (2011) 1.02
Retinoblastoma: MR imaging parameters in detection of tumor extent. Radiology (2005) 1.01
Major vault protein, a marker of drug resistance, is upregulated in refractory epilepsy. Epilepsia (2003) 1.01
Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions. Free Radic Biol Med (2010) 1.00
Phagocytes containing a disease-promoting Toll-like receptor/Nod ligand are present in the brain during demyelinating disease in primates. Am J Pathol (2006) 1.00
The role of perivascular and meningeal macrophages in experimental allergic encephalomyelitis. J Neuroimmunol (2002) 0.99
Demyelination during multiple sclerosis is associated with combined activation of microglia/macrophages by IFN-γ and alpha B-crystallin. Acta Neuropathol (2014) 0.99
Leukaemia cutis: clinical features and treatment strategies. Haematologica (2002) 0.98
Soluble helminth products suppress clinical signs in murine experimental autoimmune encephalomyelitis and differentially modulate human dendritic cell activation. Mol Immunol (2012) 0.98
Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets. J Neuropathol Exp Neurol (2008) 0.98
Autoimmune tolerance eliminates relapses but fails to halt progression in a model of multiple sclerosis. J Neuroimmunol (2005) 0.98
Immunization with neurofilament light protein induces spastic paresis and axonal degeneration in Biozzi ABH mice. J Neuropathol Exp Neurol (2007) 0.98
Homing properties of adipose-derived stem cells to intracerebral glioma and the effects of adenovirus infection. Cancer Lett (2008) 0.97
CXC-chemokines KC and macrophage inflammatory protein-2 (MIP-2) synergistically induce leukocyte recruitment to the central nervous system in rats. Immunol Lett (2003) 0.97
Leukemia inhibitory factor modulates production of inflammatory mediators and myelin phagocytosis by macrophages. J Neuroimmunol (2008) 0.97
The microtubule regulator stathmin is an endogenous protein agonist for TLR3. J Immunol (2010) 0.97
Macrophages migrate in an activation-dependent manner to chemokines involved in neuroinflammation. J Neuroinflammation (2014) 0.97